Abstract

Sphingolipids (SLs) are lipids derived from sphingosine, and their metabolism involves a broad and complex network of reactions. Although SLs are widely distributed in the body, it is well known that they are present in high concentrations within the central nervous system (CNS). Under physiological conditions, their abundance and distribution in the CNS depend on brain development and cell type. Consequently, SLs metabolism impairment may have a significant impact on the normal CNS function, and has been associated with several disorders, including sphingolipidoses, Parkinson's, and Alzheimer's. This review summarizes the main SLs characteristics and current knowledge about synthesis, catabolism, regulatory pathways, and their role in physiological and pathological scenarios in the CNS.

Original languageEnglish
Article number100900
JournalAdvances in Biological Regulation
Volume85
DOIs
StatePublished - Aug 2022

Keywords

  • Central nervous system
  • Lysosomal storage diseases
  • Sphingolipidoses
  • Sphingolipids

Fingerprint

Dive into the research topics of 'Sphingolipids and their role in health and disease in the central nervous system'. Together they form a unique fingerprint.

Cite this